Acadian Asset Management LLC Vertex Pharmaceuticals Inc Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 5,743 shares of VRTX stock, worth $2.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,743

Previous 21,091 72.77%

Holding current value

$2.35 Million

Previous $9.88 Million 73.02%

% of portfolio

0.01%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $7.06 Million - $7.76 Million	-15,348 Reduced 72.77%	5,743 $2.66 Million
Q2 2024 Aug 06, 2024	BUY	$392.81 - $485.53 $1.28 Million - $1.58 Million	3,257 Added 18.26%	21,091 $9.88 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $284,159 - $310,917	-697 Reduced 3.76%	17,834 $7.44 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $1.96 Million - $2.35 Million	-5,725 Reduced 23.6%	18,531 $7.53 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $146,093 - $156,582	432 Added 1.81%	24,256 $8.43 Million
Q2 2023 Aug 07, 2023	SELL	$314.42 - $351.91 $4.18 Million - $4.68 Million	-13,296 Reduced 35.82%	23,824 $8.37 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $34.1 Million - $38.9 Million	-120,321 Reduced 76.42%	37,120 $11.7 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $10.2 Million - $11.4 Million	35,552 Added 29.17%	157,441 $45.4 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $28.3 Million - $31.6 Million	103,314 Added 556.2%	121,889 $35.3 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $28.3 Million - $31.6 Million	103,314 Added 556.2%	121,889 $35.3 Million
Q2 2022 Aug 09, 2022	SELL	$234.96 - $292.55 $1.38 Million - $1.72 Million	-5,882 Reduced 24.05%	18,575 $5.23 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $3.41 Million - $4.01 Million	15,380 Added 169.44%	24,457 $6.38 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $58.2 Million - $73.5 Million	-328,874 Reduced 97.31%	9,077 $1.99 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $16 Million - $17.9 Million	88,374 Added 35.41%	337,951 $61.3 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $37.4 Million - $44.1 Million	199,401 Added 397.4%	249,577 $50.3 Million
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $910,888 - $1.06 Million	4,400 Added 9.61%	50,176 $10.8 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $5.02 Million - $6.7 Million	24,272 Added 112.87%	45,776 $10.8 Million
Q3 2020 Nov 09, 2020	BUY	$255.65 - $303.1 $1.03 Million - $1.22 Million	4,028 Added 23.05%	21,504 $5.85 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $2.82 Million - $3.7 Million	12,505 Added 251.56%	17,476 $5.08 Million
Q1 2020 May 11, 2020	BUY	$199.77 - $247.81 $755,929 - $937,713	3,784 Added 318.79%	4,971 $1.18 Million
Q4 2019 Feb 06, 2020	BUY	$166.71 - $223.91 $197,884 - $265,781	1,187 New	1,187 $260,000
Q2 2019 Aug 08, 2019	SELL	$164.61 - $190.37 $140,576 - $162,575	-854 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$163.73 - $194.7 $2.94 Million - $3.5 Million	-17,962 Reduced 95.46%	854 $157,000
Q4 2018 Feb 07, 2019	SELL	$151.91 - $192.21 $716,407 - $906,462	-4,716 Reduced 20.04%	18,816 $3.12 Million
Q3 2018 Oct 30, 2018	BUY	$167.73 - $192.74 $3.17 Million - $3.65 Million	18,926 Added 410.9%	23,532 $4.54 Million
Q2 2018 Jul 24, 2018	SELL	$145.72 - $169.96 $23,606 - $27,533	-162 Reduced 3.4%	4,606 $784,000
Q1 2018 Apr 12, 2018	SELL	$151.6 - $177.13 $2.28 Million - $2.66 Million	-15,022 Reduced 75.91%	4,768 $777,000
Q4 2017 Jan 18, 2018	SELL	$137.28 - $155.55 $24.5 Million - $27.8 Million	-178,403 Reduced 90.01%	19,790 $2.97 Million
Q3 2017 Oct 13, 2017	BUY	$148.13 - $162.24 $29.4 Million - $32.2 Million	198,193	198,193 $30.1 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Vertex Pharmaceuticals Inc Transaction History